Layout Table~~~~1415~1415~~

RNAi/MicroRNA Market 2007~
Published by Select Biosciences, February 2007

This report presents an industry analysis of the RNAi and microRNA markets in both qualitative and quantitative terms. Select Biosciences’ industry tracking of these spaces involves analyses of the technology trends as well as market analysis. Select Biosciences presents primary market survey data in this report that describes the qualitative and quantitative metrics in the RNAi and microRNA markets.~
Published by Select Biosciences, February 2007

This report presents an industry analysis of the RNAi and microRNA markets in both qualitative and quantitative terms. Select Biosciences’ industry tracking of these spaces involves analyses of the technology trends as well as market analysis. Select Biosciences presents primary market survey data in this report that describes the qualitative and quantitative metrics in the RNAi and microRNA markets.

Topics Covered in This Report

Market analysis of the microRNA space—primary market research data
Market opportunity in the microRNA research space, market size, growth rate
Technologies for RNA interference [RNAi]
Commercial products and formats for inducing RNAi
RNAi space: Industry SWOT analysis
Market analysis of the RNAi space—primary market research data
Market opportunity in the RNAi space, market size, growth rate

Table of contents~RNAi/MicroRNA Market 2007 (Single User Print Version)|732|RNAi/MicroRNA Market 2007 (Electronic Site License)|836|~1415~2697~~

Automated Low Volume Dispensing Trends 2006~
Published by HTStec, June 2006

This market report summarizes the results of a comprehensive global Pharma/Biotech and Academia web-based survey on automated low volume (nanoliter) dispensing. The survey looked at current and future use of low volume dispensing; plans and interest in the purchase of automated nL dispensing systems; applications for the use of nL dispensing; whether the systems should include detection capability, function stand-alone and whether additional functionality should be integrated with the dispenser to create a useful system; current and future total assay volume requirements; preferred method of integration and questions relating to acoustic droplet ejection (ADE).~
Published by HTStec, June 2006

This market report summarizes the results of a comprehensive global Pharma/Biotech and Academia web-based survey on automated low volume (nanoliter) dispensing. The survey looked at current and future use of low volume dispensing; plans and interest in the purchase of automated nL dispensing systems; applications for the use of nL dispensing; whether the systems should include detection capability, function stand-alone and whether additional functionality should be integrated with the dispenser to create a useful system; current and future total assay volume requirements; preferred method of integration and questions relating to acoustic droplet ejection (ADE).

Table of contents

~Automated Low Volume Dispensing Trends 2006 (PDF)|742|~1415~2581~~

Label Free Detection Trends 2006~
Published by HTStec, April 2006

This market report summarizes the results of a comprehensive global Pharma/Biotech web-based survey on the current and future status of label free detection and its applications. The survey looked at various points including current or planned use of label free detection; new technology awareness; application and technical requirements. Among the questions covered in the survey was current ownership of label free detection systems, future plans to purchase new systems, basis for selection of new platforms This report will be of great value to those vendors developing or preparing to launch new label free detection technologies and to those existing vendors seeking to improve their current offerings or check alignment of the latest market needs.

~
Published by HTStec, April 2006

This market report summarizes the results of a comprehensive global Pharma/Biotech web-based survey on the current and future status of label free detection and its applications. The survey looked at various points including current or planned use of label free detection; new technology awareness; application and technical requirements. Among the questions covered in the survey was current ownership of label free detection systems, future plans to purchase new systems, basis for selection of new platforms This report will be of great value to those vendors developing or preparing to launch new label free detection technologies and to those existing vendors seeking to improve their current offerings or check alignment of the latest market needs.

Table of contents~Label Free Detection Trends 2006 (Eletronic site license PDF)|736|~1415~2574~~

TR-FRET BASED ASSAY TRENDS~
Published by HTStec, October 2005

This market report summarizes the results of a comprehensive global Pharma/Biotech web-based survey on TR-FRET based assays. The survey looked at various points including current use of TR-FRET based assays and other generic assay technologies; reasons for choosing TR-FRET based assays over alternative assays and vice versa; whether TR-FRET was a preferred assay technology and usage/spending today; current expertise in multiple assay technologies; TR-FRET reagent budget breakdown and opinion on reagent pricing per data point.~
Published by HTStec, October 2005

This market report summarizes the results of a comprehensive global Pharma/Biotech web-based survey on TR-FRET based assays. The survey looked at various points including current use of TR-FRET based assays and other generic assay technologies; reasons for choosing TR-FRET based assays over alternative assays and vice versa; whether TR-FRET was a preferred assay technology and usage/spending today; current expertise in multiple assay technologies; TR-FRET reagent budget breakdown and opinion on reagent pricing per data point.

Table of contents~TR-FRET BASED ASSAY TRENDS (Eletronic Site License PDF)|733|~1415~2570~~

Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D~
Companies Products and WW Market, 2004-2009

Published by Takeda Pacific, July 2005

One of the big ideas that emerged since the completion of the human genome project involves new biomarkers and tests used for tailoring new drugs that match an individual’s genetic makeup. This report is about the market for genomic, metabolomic and protein biomarkers and the related tests. The tests are used as molecular diagnostics and as pharmacogenomic assays to measure drug safety or effectiveness. Takeda Pacific’s report maps out the major areas of the market ecosystem for biomarkers and related tests. This insightful study shows that this market is big business and reached $7.1 billion in 2004. The study reveals that molecular diagnostic companies are poised for continued strong growth. The mix of pharma/ biotech companies doing biomarker related R&D is also beginning to show gains.

~Companies Products and WW Market, 2004-2009

Published by: Takeda Pacific, July 2005


One of the big ideas that emerged since the completion of the human genome project involves new biomarkers and tests used for tailoring new drugs that match an individual’s genetic makeup. This report is about the market for genomic, metabolomic and protein biomarkers and the related tests. The tests are used as molecular diagnostics and as pharmacogenomic assays to measure drug safety or effectiveness. Takeda Pacific’s report maps out the major areas of the market ecosystem for biomarkers and related tests. This insightful study shows that this market is big business and reached $7.1 billion in 2004. The study reveals that molecular diagnostic companies are poised for continued strong growth. The mix of pharma/ biotech companies doing biomarker related R&D is also beginning to show gains.

The study projects the 5-year trends for biomarkers, molecular diagnostics and pharmacogenomic tests used by the drug makers. The report charts the developments of more than 50 companies involved in this dynamic industry.

This report discusses new FDA initiatives to accelerate the approvals of emerging diagnostics and new drugs by integrating biomarkers and pharmacogenomic tests drug development from pre-clinical through the end of clinical trial phases. Companies have responded with new products. Roche’s new microarray test, targets certain gene variants, and tests if patients respond well to 30 or more currently marketed drugs. Tailored therapies such as Herceptin, Gleevec, Erbitux, or Irressa are among a new class of marketed products. They work very effectively, but just for a sub-set of individuals that pass special genetic tests designed for each product. These products signal that the era of personalized medicine has begun.

This study is packed with interesting data and includes more than 66 figures and tables. The tables provide data about technologies, companies, product pipelines, partnerships and more. The study also has additional data such as the worldwide incidence and prevalence of major diseases. The report analyzes partnering deals and includes several years of alliance and M&A data.

Twenty-two selected companies are profiled, with details including contact information, business and product overviews, alliances and patent or other financial details. This report would benefit people with job titles including CEO, VPs, Director of Business Development, Research Directors, Entrepreneurs, Venture Capitalists, Investment Planners, Research Scientists, Consultants or Industry Analysts.

Table of Contents~Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D%3A PDF Single User License|52|Biomarkers and Related Tests for Molecular Diagnostics and Pharma/ Biotech R&D%3A Site License|53|~1415~2687~~

Molecular Diagnostics~
Published by Select Biosciences, Spring 2005


The molecular diagnostics marketplace offers a growth opportunity given the interest in utilizing molecular tools to precisely target therapeutics.

This report analyzes the technologies and their impact in the molecular diagnostics marketplace. An assessment of all the technologies of value in this market and which market segments are impacted and affected by these technologies.

Furthermore, in this report are presented qualitative and quantitative market analysis of molecular diagnostics. Presented are total industry revenues, growth rates, and the various qualitative drivers that are contributing to the growth of the marketplace.
~Published by Select Biosciences, Spring 2005

The molecular diagnostics marketplace offers a growth opportunity given the interest in utilizing molecular tools to precisely target therapeutics.

This report analyzes the technologies and their impact in the molecular diagnostics marketplace. An assessment of all the technologies of value in this market and which market segments are impacted and affected by these technologies.

Furthermore, in this report are presented qualitative and quantitative market analysis of molecular diagnostics. Presented are total industry revenues, growth rates, and the various qualitative drivers that are contributing to the growth of the marketplace.

Key Highlights of this Report:

• Qualitative and quantitative market analyses, and market forecasts
• Technology assessment and competitive analysis
• All the major technology platforms deployed in molecular diagnostics:
    o Instrumentation
    o Complete Assay Technologies
• Approval processes for molecular diagnostics for US, European Union, and Japan are presented. This is key information for new entrants into this marketplace.
• Segments of the molecular diagnostics marketplace
• Qualitative market drivers
• Quantitative Market Analysis
    o Total market size in terms of industry revenues and growth rate
    o Emerging market segments-and estimated market sizes
    o Growth areas in terms of classes of analytes-biological targets for development of molecular diagnostics

Table of contents | Sample Pages ~Molecular Diagnostics (single user print version)|757|Molecular Diagnostics (Eletronic site license PDF + One print Copy)|758|~1415~2608~~

Tissue Microarrays~
Published by Select Biosciences, May 2004

The report provides in-depth information on the market and size segmented by technology and application. In addition to a detailed market model, Tissue Microarrays : Market Assessment and Opportunities evaluates the strengths and weaknesses of each of the TMA vendors, and assesses both opportunities and threats facing their products & services. The companies most likely to dominate specific market segments, as well as the companies most likely to play key supporting roles in moving technologies forward are identified.
~Published by Select Biosciences, May 2004


The report provides in-depth information on the market and size segmented by technology and application. In addition to a detailed market model, Tissue Microarrays : Market Assessment and Opportunities evaluates the strengths and weaknesses of each of the TMA vendors, and assesses both opportunities and threats facing their products & services. The companies most likely to dominate specific market segments, as well as the companies most likely to play key supporting roles in moving technologies forward are identified.


View Full Table of Contents~Tissue Microarrays%3A Full Report - Single user print version|48|Tissue Microarrays%3A Full Report - PDF site License +1 print copy|621|~1415~1701~~